Atea Pharmaceuticals, Inc.
← Back to AVIR Overview

Atea Pharmaceuticals, Inc. (AVIR)

Price-to-Earnings Ratio History

P/E Ratio (TTM)

-2.36

Financial Fundamentals

AVIRQuarterly Data • 5Y View

Quarterly P/E

QuarterP/E Ratio
2019-03-31-34.48
2019-06-30-21.67
2019-09-30-98.76
2019-12-31-77.08
2020-03-31-89.98
2020-06-30-36.12
2020-09-30-34.48
2020-12-3141.78
2021-03-3141.72
2021-06-30268.50
2021-09-30-25.78
2021-12-311.59
2022-03-31-3.61
2022-06-30-4.67
2022-09-30-14.68
2022-12-31-2.93
2023-03-31-1.95
2023-06-30-2.75
2023-09-30-1.88
2023-12-31-1.62
2024-03-31-1.33
2024-06-30-1.76
2024-09-30-2.26
2024-12-31-2.09
2025-03-31-1.87
2025-06-30-2.05
2025-09-30-1.37
2025-12-31-1.57
2026-03-31-2.36

* P/E ratios are calculated using trailing twelve-month (TTM) earnings.

Atea Pharmaceuticals, Inc. (AVIR) P/E Ratio History & Valuation Cycles